genotype

Documents about genotype

• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection#1339611ClinicalTrials.gov
• Trial in Adult Participants With Spinocerebellar Ataxia (SCA)#969480ClinicalTrials.gov
• Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection#902612ClinicalTrials.gov
• Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6#1103932ClinicalTrials.gov
• HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b#841154ClinicalTrials.gov
• 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain#1430204ClinicalTrials.gov
• Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada#1464619ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis#855943ClinicalTrials.gov
• A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1#1086402ClinicalTrials.gov
• GenoBERT: A Language Model for Accurate Genotype Imputation#810027DigitalCommons@Kennesaw State University
• Isoniazid Dosage Prediction Model Development#870774ClinicalTrials.gov
• Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection#863329ClinicalTrials.gov
• CYP2D6 Genotype on the Clinical Effect of Tamoxifen#857526ClinicalTrials.gov
• Telaprevir in Genotype 3 HCV#980123ClinicalTrials.gov
• Impact of CES1 Genotype on Metabolism of Methylphenidate#1464742ClinicalTrials.gov
• Genotype and Phenotype in Pediatric Familial Mediterranean Fever#1465707ClinicalTrials.gov
• The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)#1322038ClinicalTrials.gov
• Inference of Population Structure Using Multilocus Genotype Data#6300OpenAlex
• Genotype-guided Targeted Agents Plus EZH2i for Primary Refractory PTCL#866701ClinicalTrials.gov
• Hepatitis C (HCV) Cure and Kidney Health#904673ClinicalTrials.gov
• A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection#829216ClinicalTrials.gov
• Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment#892615ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)#1445129ClinicalTrials.gov
• Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection#843011ClinicalTrials.gov
• Genotype Guided Antiplatelet Therapy In Ischemic Stroke#800769ClinicalTrials.gov
• Genotype imputation and GWAS datasets for pearl millet#1345399Figshare
• Cerebellar DBS in SCA1 and SCA3 Study#1437300ClinicalTrials.gov
• Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b#1439551ClinicalTrials.gov
• Phase 3 Study of Sofosbuvir and Ribavirin#848530ClinicalTrials.gov
• AI-Driven Genotype Prediction Using EHR and Multimodal Data#878492ClinicalTrials.gov
• AMD Phenotype and Genotype Study#856555ClinicalTrials.gov
• Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment#1045645ClinicalTrials.gov
• The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection#1365864ClinicalTrials.gov
• Beyond Mendel: a call to revisit the genotype-phenotype map through new experimental paradigms#5743Europe PMC
• Inference of Population Structure Using Multilocus Genotype Data: Linked Loci and Correlated Allele Frequencies#7212OpenAlex
• China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype#138657ClinicalTrials.gov
• Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection#1352403ClinicalTrials.gov
• Evaluation of quinoa (Chenopodium quinoa Willd.) genotypes using genotype by trait (GT) and genotype by yield × trait (GYT) methods.#258441NCBI PubMed Central
• Mitochondrial genotype decreases mitochondrial respiration in seed beetles: implications for male subfertility#326379IBISS
• The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160)#1243493ClinicalTrials.gov
• Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants#1153118ClinicalTrials.gov
• A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients#1172103ClinicalTrials.gov
• Beyond Mendel: A call to revisit the genotype–phenotype map through new experimental paradigms#206105ISTA Publications
• Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa#872351ClinicalTrials.gov
• Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1#967025ClinicalTrials.gov
• Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients#981001ClinicalTrials.gov
• TBC1D24 genotype-phenotype correlation#1005399The University of Melbourne Library Digital Repository
• Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2#826060ClinicalTrials.gov
• Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene#902229ClinicalTrials.gov
• Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics#1093023ClinicalTrials.gov